card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Validating Flow Cytometry Assays for Immuno Oncology Trials in the Central Lab

Molecular Medicine Tri-Conference 2017
Home / Insights / Validating Flow Cytometry Assays for Immuno Oncology Trials in the Central Lab

Presented at Molecular Medicine Tri-Conference 2017, this presentation provides an overview of assay development, validation, and deployment of flow cytometry analysis in immuno-oncology trials. With the expansion of immuno-oncology pipelines, flow cytometry has become a key tool for drug developers, offering new opportunities for immune characterization of samples that can support the development of predictive biomarkers for optimized patient selection, correlation of activation profile to response, and retrospective data analysis. 

Download this presentation to learn how to effectively utilize flow cytometry, following best practices including assay development, validation, technology transfer, instrument standardization, and more. IQVIA Laboratories is helping its customers effectively utilize flow cytometry services by offering the largest global footprint for flow cytometry services, innovative technology that provides high quality data with minimal variability, and continuous improvement efficiency initiatives to meet customers' individual needs.

Speaker:
Alistair Watt, Ph.D., Director, Translational Science Laboratory, Europe